Fabino Life Sciences IPO vs Precision Metaliks IPO

Comparison between Fabino Life Sciences IPO and Precision Metaliks IPO.

IPO Details

Fabino Life Sciences IPO is a SME Fixed Price IPO proposed to list at BSE SME while Precision Metaliks IPO is a SME Fixed Price proposed to list at NSE SME.

Issue Size and Price

The total issue size of Fabino Life Sciences IPO is up to ₹3.07 Cr whereas the issue size of the Precision Metaliks IPO is up to ₹20.83 Cr. The final issue price of Fabino Life Sciences IPO is ₹36.00 per share and of Precision Metaliks IPO is ₹51.00 per share.

 Fabino Life Sciences IPOPrecision Metaliks IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹36.00 per share₹51.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size3000 shares2000 shares
Fresh Issue Size8,52,000 shares40,84,000 shares
Fresh Issue Size (Amount)up to ₹3.07 Crup to ₹20.83 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total8,52,000 shares40,84,000 shares
Issue Size Total (Amount)up to ₹3.07 Crup to ₹20.83 Cr

IPO Timetable

Fabino Life Sciences IPO opens on Dec 31, 2021, while Precision Metaliks IPO opens on Jan 19, 2022. The closing date of Fabino Life Sciences IPO and Precision Metaliks IPO is Jan 05, 2022, and Jan 24, 2022, respectively.

 Fabino Life Sciences IPOPrecision Metaliks IPO
Issue OpenDec 31, 2021Jan 19, 2022
Issue CloseJan 05, 2022Jan 24, 2022
Basis Of Allotment (Tentative)Jan 10, 2022Jan 28, 2022
Initiation of Refunds (Tentative)Jan 11, 2022Jan 31, 2022
Credit of Share (Tentative)Jan 12, 2022Feb 01, 2022
Listing date (Tentative)Jan 13, 2022Feb 01, 2022

Financials & KPIs

Fabino Life Sciences IPO P/E ratio is 133, as compared to Precision Metaliks IPO P/E ratio of 19.32.

 Fabino Life Sciences IPOPrecision Metaliks IPO
Financials

Company Financials (Restated)

Period Ended30 Jun 202131 Mar 202131 Mar 202031 Mar 2019
Assets2.812.253.598.55
Total Income1.133.067.522.76
Profit After Tax0.010.030.070.00
EBITDA0.030.060.320.32
NET Worth1.321.300.670.60
Reserves and Surplus0.120.100.520.45
Total Borrowing0.420.311.082.52
Amount in ₹ Crore

Company Financials (Restated)

Period Ended30 Sep 202131 Mar 202131 Mar 202031 Mar 2019
Assets20.2321.4813.673.03
Total Income48.1349.2422.180.05
Profit After Tax2.151.490.820.00
EBITDA2.661.650.880.01
NET Worth17.5115.3610.580.47
Reserves and Surplus5.5514.109.550.42
Total Borrowing0.000.000.000.00
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)99.43%79.7%
Promoter Shareholding (Post-Issue)56.82%58.62%
P/E Ratio13319.32
Market Cap₹7.56 Cr.₹82.92 Cr.
EPS₹14.42
RoNW9.72

Shares Offered

In the Fabino Life Sciences IPO Retail Individual Investors (RII) are offered 4,26,000 shares while in Precision Metaliks IPO retail investors are offered 4,26,000 shares. Qualified Institutional Buyers (QIB) are offered in Fabino Life Sciences IPO and in Precision Metaliks IPO.

 Fabino Life Sciences IPOPrecision Metaliks IPO
Market Maker Reservation48,000 shares2,16,000 shares
NII4,26,000 shares20,42,000 shares
RII4,26,000 shares20,42,000 shares
Total8,52,000 shares40,84,000 shares

Bids Received (Subscription)

Fabino Life Sciences IPO subscribed 6.93x in total, whereas Precision Metaliks IPO subscribed 7.36x.

 Fabino Life Sciences IPOPrecision Metaliks IPO
NII (times)3.49x2.81x
RII (times)10.36x11.90x
Total (times)6.93x7.36x

Compare with others

Compare:

Fabino Life Sciences IPO Vs Precision Metaliks IPO